Anti-TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).
Guillaume Le BautLaurent Peyrin BirouletGuillaume BouguenJean-Marc GornetCarmen StefanescuAurélien AmiotDavid LaharieRomain AltweggMathurin FumeryCaroline Trang-PoissonLucine VuittonMarion SimonCyrielle Gilletta de Saint JosephStéphane NahonLudovic CailloEmilie Del TedescoLaurianne PlastarasAlexandre AubourgGuillaume Pineton de ChambrunPhilippe SeksikStéphanie ViennotPublished in: Alimentary pharmacology & therapeutics (2018)
In the anti-TNF era, approximately one-third of patients with genital fistula in Crohn's disease had complete fistula closure at 1 year. Collaboration between surgeons and gastroenterologists appears to be very important to improve the rate of fistula closure.
Keyphrases